192
Views
17
CrossRef citations to date
0
Altmetric
Articles

Comparison of fibrin clots derived from peripheral blood and bone marrow

, , , , , & show all
Pages 208-214 | Received 14 Dec 2015, Accepted 13 Jul 2016, Published online: 22 Aug 2016

References

  • Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341(10):738–46.
  • Arnoczky SP, Warren RF, Spivak JM. Meniscal repair using an exogenous fibrin clot. An experimental study in dogs. J Bone Joint Surg Am 1988;70(8):1209–17.
  • Chen YC, Wang SJ, Shen PH, Huang GS, Lee HS, Wu SS. Intraosseous ganglion cyst of the capitate treated by intralesional curettage, autogenous bone marrow graft and autogenous fibrin clot graft. J Chin med Assoc 2007;70(5):222–6.
  • Catelas I, Dwyer JF, Helgerson S. Controlled release of bioactive transforming growth factor beta-1 from fibrin gels in vitro. Tissue Eng Part C Methods 2008;14(2):119–28.
  • Seybold D, Schildhauer TA, Gessmann J, Muhr G, Köller M, Roetman B. Osteogenic differentiation of human mesenchymal stromal cells is promoted by a leukocytes containing fibrin matrix. Langenbecks Arch Surg 2010;395(6):719–26.
  • Knighton DR, Hunt TK, Thakral KK, Goodson WH 3rd. Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg 1982;196(4):379–88.
  • Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005 Aug;3(8):1894–904.
  • Whatley JS, Dejardin LM, Arnoczky SP. The effect of an exogenous fibrin clot on the regeneration of the triangular fibrocartilage complex: an in vivo experimental study in dogs. Arthroscopy 2000;16(2):127–36.
  • Trombi L, Mattii L, Pacini S, D’Alessandro D, Battolla B, Orciuolo E, Buda G, Fazzi R, Galimberti S, Petrini M. Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing. J Orthop Res 2008;26(2):176–83.
  • Schildhauer TA, Seybold D, Geßmann J, Muhr G, Koller M. Fixation of porous calcium phosphate with expanded bone marrow cells using an autologous plasma clot. Mater Sci Eng Technol 2007;38(12):1012–14.
  • Jäger M, Herten M, Fochtmann U, Fischer J, Hernigou P, Zilkens C, Hendrich C, Krauspe R. Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 2011;29(2):173–80.
  • Giannotti S, Trombi L, Bottai V, Ghilardi M, D’Alessandro D, Danti S, Dell’Osso G, Guido G, Petrini M. Use of autologous human mesenchymal stromal cell/fibrin clot constructs in upper limb non-unions: long-term assessment. PLoS One 2013;8(8):e73893.
  • Proctor CS. Rotator cuff repair augmented with endogenous fibrin clot. Arthrosc Tech 2012;1(1):e79–82.
  • Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004;329(1):77–84.
  • Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999;107(2):275–81.
  • Kim HJ, Kang SW, Lim HC, Han SB, Lee JS, Prasad L, Kim YJ, Kim BS, Park JH. The role of transforming growth factor-beta and bone morphogenetic protein with fibrin glue in healing of bone-tendon junction injury. Connect Tissue Res 2007;48(6):309–15.
  • Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, Epstein SE. Local delivery of marrow derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109(12):1543–9.
  • Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res 2003;44 Suppl 1:305–11.
  • Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008;3(4):e1886.
  • Awad HA, Butler DL, Boivin GP, Smith FN, Malaviya P, Huibregtse B, Caplan AI. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 1999;5(3):267–277.
  • Bernardo ME, Emons JA, Karperien M, Nauta AJ, Willemze R, Roelofs H, Romeo S, Marchini A, Rappold GA, Vukicevic S, Locatelli F, Fibbe WE. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect Tissue Res 2007;48(3):132–40.
  • Awad HA, Butler DL, Harris MT, Ibrahim RE, Wu Y, Young RG, Kadiyala S, Boivin GP. In vitro characterization of mesenchymal stem cell-seeded collagen scaffolds for tendon repair: Effects of initial seeding density on contraction kinetics. J Biomed Mater Res 2000 Aug;51(2):233–40.
  • Wakitani S, Yamamoto T. Response of the donor and recipient cells in mesenchymal cell transplantation to cartilage defect. Microsc Res Tech 2002 Jul 1;58(1):14–18.
  • Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003 Dec;48(12):3464–3474.
  • CL Cetrulo Jr, Knox KR, Brown DJ, Ashinoff RL, Dobryansky M, Ceradini DJ, Capla JM, Chang EI, Bhatt KA, McCarthy JG, Gurtner GC. Stem cells and distraction osteogenesis: endothelial progenitor cells home to the ischemic generate in activation and consolidation. Plast Reconstr Surg 2005;116(4):1053–64.
  • Li Y, Titterington J, Song Y-H, Reger R, Delafontaine P. Differential effects of IGF-1 and VEGF on migration, proliferation and differentiation of bone marrow-derived mesenchymal stem cells. Circulation 2006;114:II_84–85.
  • Kim MD, Kim SS, Cha HY, Jang SH, Chang DY, Kim W, Suh-Kim H, Lee JH. Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis. Exp Mol Med 2014;46:e110.
  • Zhang L, Zhang L, Lan X, Xu M, Mao Z, Lv H, Yao Q, Tang P. Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures. J Mater Sci Mater Med 2014;25(4):1165–72.
  • Carter AM, Cymbalista CM, Spector TD, Grant PJ, EuroCLOT Investigators. Heritability of clot formation, morphology, and lysis: the EuroCLOT study. Arterioscler Thromb Vasc Biol 2007;27(12):2783–89.
  • Olinescu R, Kummerow F. Fibrinogen is an efficient antioxidant. J Nutr Biochem 2001;12(3):162–9.
  • Wolberg AS, Monroe DM, Roberts HR, Hoffman M. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood 2003;101(8):3008–13.
  • Undas A, Ariëns RA. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol 2011;31(12):e88–99.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.